IMMPHENTIV 100 ug/mL

IMMPHENTIV 100 ug/mL is a liposomal injectable solution containing phenylephrine hydrochloride. It is used for intravenous administration and is manufactured by Hikma Pharmaceuticals USA Inc.

IMMPHENTIV 100 ug/mL is a medication that contains phenylephrine hydrochloride, a sympathomimetic amine. It is commonly used for its vasoconstrictive properties, which can help manage certain cardiovascular conditions. The primary use of phenylephrine is to increase blood pressure in situations where it has dropped dangerously low. It may also be used in other medical settings where a quick and effective vasoconstrictor is needed.

When administered intravenously, IMMPHENTIV 100 ug/mL works by stimulating alpha-adrenergic receptors, leading to vasoconstriction. This can result in an increase in blood pressure and a reduction in blood flow to certain areas of the body. Common effects may include a temporary rise in blood pressure and a decrease in heart rate. The liposomal formulation is designed to provide a controlled release of the active ingredient.

IMMPHENTIV 100 ug/mL should be handled with care and administered by healthcare professionals. It is important to follow proper storage and handling guidelines to maintain the integrity of the liposomal formulation. Patients with certain cardiovascular conditions or those taking other medications should consult their healthcare provider before use. Always follow the prescribed dosage and administration instructions.

IMMPHENTIV 100 ug/mL may interact with other medications, particularly those that affect blood pressure or heart rate. Common interacting substances include other vasoconstrictors, beta-blockers, and certain antidepressants. Alcohol and other central nervous system depressants may also interact with phenylephrine. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.